Flow cytometry analysis of hilum and mediastinum lymphadenopathy taken by EBUS-TBNA

Flow cytometry analysis of hilum and mediastinum lymphadenopathy taken by EBUS-TBNA - Flow cytometry analysis of hilum and mediastinum lymphadenopathy taken by EBUS-TBNA

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000021850

Enrollment

Registered

2016-04-10

Start date

2016-04-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hilum and mediastinum lymphadenopathy

Interventions

Collection of the specimen by EBUS-TBNA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The case who have mediastinumand hilum lymphadenopathy.

Exclusion criteria

Exclusion criteria: The case that an agreement was not provided

Design outcomes

Primary

Measure	Time frame
Correlation of immune cell ratio in the lymph node,and disease prognosis	—

Countries

Japan

Contacts

Public ContactTomoyuki Minezawa

Fujita Health University School of Medicine Division of Respiratory Medicine and Clinical Allergy

minezawa@fujita-hu.ac.jp0562-93-9241

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026